Aims-To analyse the diagnostic differences in reporting tumour histopathology between a district general hospital and a regional oncology centre. Methods-Tumour histopathology reports (n = 227) extracted from Bolton General Hospital files between 1988 and 1992 were compared with the corresponding Christie Hospital (oncology centre) reports, the same material having been seen at both hospitals. Results-Diagnostic agreement existed in 77% of all cases. The incidence of major discrepancies was 8-37%. Ofthe diagnoses, 19 (36%) cases involved major discrepancies and 34 (64%) cases minor discrepancies. Most discrepancies occurred in the lymphoma group and involved subclassification ofHodgkin's and non-Hodgkin's lymphoma. Kil anaplastic large cell lymphoma and T cell rich B cell lymphoma were problematic diagnoses. The correct grading of follicle centre cell lymphomas using the Kiel classification was another problem area. In 19 cases certain aspects of immunohistochemistry produced discrepancies. In one case an incorrect diagnosis was made at the oncology centre and in another both centres gave an incorrect diagnosis. Conclusions-Areas of diagnostic difficulty mainly involve the subclassification of lymphomas. Review of tumour pathology by experts is recommended, at least in certain categories, to ensure correct diagnosis and uniformity in subclassification of tumours.
Quality assessment in histopathology is now commonplace and takes the form of internal and external quality control systems."2 Review of histopathological cases by specialist panels, either for opinions or confirmation of diagnoses before further investigation or treatment at specialist centres, has been taking place for many years.
Bolton General Hospital is a district general hospital which refers selected patients with malignant neoplastic conditions to a regional cancer treatment centre, the Christie Hospital, for specialist surgery, radiotherapy and chemotherapy. It is customary practice for selected histological diagnoses reached at Bolton General Hospital to be reviewed at Christie Hospital by their pathologists, who have a specialist interest in neoplastic conditions and receive material from the whole of the North West region. Histological reports made at Bolton General Hospital are sent with unstained sections or blocks, or both, to the Christie Hospital pathology department where, following assessment, a copy of their pathological findings is sent back to Bolton General Hospital.
By comparing the diagnoses, an evaluation of the number and types of discrepancies was made. To the best of our knowledge, this type of study has not been performed before and it investigates the role of specialist pathologists as well as some of the difficult diagnostic problems in tumour pathology.
Methods
By examining the record files at Bolton General Hospital, we were able to extract 227 reports of diagnoses reached at Bolton General Hospital and reviewed at Christie Hospital, spanning a five year period from 1988 to 1992. All of the reports contained confident diagnoses made at Bolton General Hospital and referred cases seeking a second opinion were excluded. Each dual report was examined and any diagnostic discrepancies were recorded and divided into major and minor differences. Major discrepancies were defined as those errors The second major discrepancy involved incorrect grading of a follicle centre cell lymphoma (case 4). The two minor discrepancies involved subclassification of malignant melanomas.
OTHER SITES
Three major discrepancies and six minor discrepancies were found (table 6). The major discrepancies included (a) misdiagnosis of malignant melanoma based on conflicting immunohistochemical results between the two centres. At Bolton General Hospital this poorly differentiated bronchial neoplasm showed Cam 5f2 positive and S-100 negative staining, whereas at Christie Hospital the tumour showed S-100 positive and Cam 5-2, EMA (epithelial membrane antigen) negative staining (case 8); (b) incorrect grading of follicle centre cell lymphoma (case 13); (c) misdiagnosis of acute myeloid leukaemia (case 7). The leukaemic infiltrate was chloroacetate esterase positive; this stain was not carried out at Bolton General Hospital.
The minor discrepancies were varied. In case 5 further biopsy specimens at Christie Hospital showed features of malignant teratoma. The cells on which a diagnosis of liposarcoma was made at Bolton General Hospital were most probably cells with degenerative vacuoles rather than true lipoblasts.
Case 10 represents a difference in the interpretation of stromal invasion in bladder transitional cell carcinomas. Case 12 represents an immunohistochemical discrepancy.
Discussion
One purpose of this audit was to categorise the types of errors and areas of diagnostic difficulty experienced in tumour pathology by pathologists at a district general hospital. By highlighting these problem areas, efforts to increase diagnostic knowledge can be made. At the same time, this audit sheds light on the necessity and role of specialist referral centres, particularly in the cost-conscious, competitive market that we, as pathologists, are having to embrace.
It is notable that in none ofthe 53 instances of diagnostic disagreement was a benign/reactive condition called malignant or vice versa. Most errors occurred in tumour subclassification.
In the lymphoid group the problem of diagnosing Kil ACL was apparent. This lymphoma can closely mimic metastatic carcinoma and Hodgkin's disease in haematoxylin and eosin preparations. The cells can also show EMA positive staining as well as a variety of staining patterns with T cell and B cell lymphocyte markers,3 including LCA negative staining in a proportion of cases. It is important to be aware of this entity when dealing with malignant large cell infiltrates and to include the Ber H2 marker in an investigative immunohistochemical panel.
T cell rich B cell lymphoma is a rare condition which, in this study, was misdiagnosed as Hodgkin's disease or T cell lymphoma. Numerous reactive small T lymphocytes are seen together with fewer neoplastic monoclonal blast cells of B cell lineage. A recent study of 26 cases showed the most common misdiagnosis was Hodgkin's disease. 4 Inconsistencies in the diagnosis of nonHodgkin's and Hodgkin's lymphomas similar to those encountered in this study have been documented previously.5 Coppleston et a16 recommended a concensus diagnosis by a team of pathologists. The distinction between low and high grade FCC lymphomas is therapeutically important and the misinterpretation of the proportions and cell types suggests problems in distinguishing centrocytes from centroblasts.
Inconsistencies in the application of the terms diffuse, follicular and diffuse and follicular to centroblastic/centrocytic lymphomas would, in practical terms, have no effect on the treatment of these lymphomas, all of which are low grade according to the Kiel classification. In the Working Formulation classification, however, these terms would have a bearing on the grade assigned.
Most of the discrepancies in the soft tissue group involved subclassification of sarcomas. There is evidence that in order to maintain a high level of diagnostic expertise in these lesions, frequent exposure to cases in necessary.7
In the North West region the incidence of soft tissue sarcoma is 18 cases per year. Studies have disclosed significant discrepancies between the initial diagnosis of sarcoma and the subsequent opinion of an expert or panel79 and in one study where the cases reviewed had been selected for treatment 5-7% of sarcoma diagnoses were revised to non-sarcoma. 9 The grading of cervical intraepithelial neoplasia (CIN) can be problematic with much intra-and interobserver variability.'0 In case 1 ( This study examined only one district hospital in the North West region. The results, though interesting, are limited and should not be regarded as generalisations for other institutions which may have greater or lesser diagnostic discrepancy levels.
Our findings show the value of having specialist referral centres which, through amassing large numbers of cases from the regional hospitals and referrals from afar, can offer a level of expertise not easily attained in peripheral hospitals. Lymphomas and soft tissue sarcomas can pose major diagnostic difficulties to the average pathologist and the exact classification ofthese tumours is important, not only in terms of correct treatment for the patient but also for epidemiological and therapeutic trial purposes. Uniformity in classification is best achieved by review of cases by pathologists with special experience. This does not mean, however, that district general hospital pathologists should opt out of making an initial diagnosis.
In view of the recent publicity about the accuracy of pathological reports, we feel that review of tumour pathology before the administration of potentially harmful radiotherapy or chemotherapy is to be encouraged and this paper suggests that this is particularly useful in certain specialised fields such as lymphoid neoplasia.
